Mark Colonnese, Paul Kinnon, Leon Richards

Nov 10, 2014

Transgenomic said this week that Mark Colonnese has resigned as CFO and executive vice president, effective Oct. 30, 2014. Transgenomics President and CEO Paul Kinnon will assume the role of interim CFO.

Additionally, Leon Richards, Transgenomic's corporate controller, will take on additional responsibilities as chief accounting officer. Richards joined the financial group at Transgenomic in 2012. Previously, he served as corporate controller and chief accounting officer at Baldwin Technology Company. Earlier in his career he was director of financial reporting and control at Ciba Specialty Chemicals (now BASF), and he also held positions of increasing responsibility in the financial group at Hercules (now Ashland Chemical).

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.